Kingston, RI, United States of America

Oleg Andreev

This inventor holds 2 USPTO granted patents. Top assignee: Cybrexa 1, Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oleg Andreev. Retrieved from https://idiyas.com/inventor/oleg-andreev-9rwcbg5j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Oleg Andreev: Innovator in Medical Treatments

Introduction

Oleg Andreev is a notable inventor based in Kingston, RI (US). He has made significant contributions to the field of medical treatments, particularly focusing on diseases involving acidic or hypoxic diseased tissues. With a total of 2 patents to his name, Andreev's work is paving the way for innovative therapeutic solutions.

Latest Patents

Andreev's latest patents include methods and compounds for the treatment of diseases characterized by acidic or hypoxic diseased tissues. His patents detail pharmaceutical compositions that comprise these compounds, as well as methods for making and using them. These innovations are crucial for advancing treatment options for patients suffering from such conditions.

Career Highlights

Oleg Andreev is currently associated with Cybrexa, Inc., where he continues to develop and refine his innovative ideas. His work is instrumental in the ongoing research and development of effective medical treatments.

Collaborations

Andreev collaborates with talented professionals in his field, including Daniel Richard Marshall and Johanna Marie Csengery. These partnerships enhance the scope and impact of his research.

Conclusion

Oleg Andreev's contributions to medical innovation are significant, particularly in the treatment of diseases involving acidic or hypoxic diseased tissues. His patents and ongoing work at Cybrexa, Inc. highlight his commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…